Table 3 Results of correlation analyses within the 3 cohorts
From: Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
AD cases | OC cases | YC cases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
pE3-Aβ | AβPP | Aβ | p-TAU | pE3-Aβ | AβPP | Aβ | p-TAU | pE3-Aβ | AβPP | Aβ | p-TAU | |
IsoD-Aβ | ρ = 0.582 | ρ = −0.026 | ρ = 0.545 | ρ = 0.336 | ρ = 0.557 | ρ = 0.591 | ρ = 0.578 | ρ = 0.289 | ρ = 0.097 | ρ = 0.145 | ρ = 0.247 | ρ = 0.382 |
p = 0.001 | p = 0.897 | p = 0.003 | p = 0.086 | p = 0.001 | p < 0.001 | p = 0.001 | p = 0.115 | p = 0.778 | p = 0.670 | p = 0.465 | p = 0.246 | |
pE3-Aβ | ρ = 0.119 | ρ = 0.098 | ρ = 0.389 | ρ = 0.570 | ρ = 0.609 | ρ = 0.380 | ρ = 0.736 | ρ = 0.663 | ρ = 0.107 | |||
p = 0.554 | p = 0.628 | p = 0.045 | p = 0.001 | p < 0.001 | p = 0.038 | p = 0.010 | p = 0.026 | p = 0.755 | ||||